1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,169 | 0,209 | 20.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | QLife Holding AB: Qlife provides business update on clinical progress, partnerships and commercialization initiatives | 91 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today provides a business update covering recent milestones, ongoing progress, and priorities for the coming... ► Artikel lesen | |
| Di | QLife Holding AB: The subscription period in Qlife's rights issue ends on Thursday, 19 March 2026 | 76 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 13.03. | QLife Holding AB: Hipro to accelerate Egoo development and regulatory approval in China following strong interest | 98 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") today announces that, following the recently communicated strong interest from hospitals in China in evaluating the Egoo platform, its strategic partner... ► Artikel lesen | |
| 05.03. | QLife Holding AB: The subscription period in Qlife's rights issue begins today | 123 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 04.03. | QLife Holding AB: Qlife publishes information document due to upcoming rights issue | 116 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 27.02. | QLife Holding AB: Qlife announces that two investors have entered agreements to subscribe for shares if the rights issue is subscribed below approx. 51.0 percent, taking over commitments from a group of guarantors | 123 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 27.02. | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.02.2026 | 273 | Xetra Newsboard | Das Instrument UZ9 CA4577022078 INSPIRATION ENERGY CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 27.02.2026 und ex Kapitalmassnahme am 02.03.2026 The instrument UZ9 CA4577022078 INSPIRATION ENERGY... ► Artikel lesen | |
| 26.02. | QLife Holding AB: Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB | 115 | GlobeNewswire (Europe) | Qlife Holding AB (the "Company" or "Qlife") held an Extraordinary General Meeting on 26 February 2026, at which the following resolutions were adopted.
Resolution on amendment of the Articles of Association
The... ► Artikel lesen | |
| QLIFE Aktie jetzt für 0€ handeln | |||||
| 25.02. | QLIFE HOLDING AB: Qlife launches pharmacy pilot project in Nordic markets | 2 | Cision News | ||
| 19.02. | QLIFE HOLDING AB: Guarantor converts guarantee commitment of SEK 0.5 million into binding subscription commitment and top guarantor waives guarantee compensation in Qlife's ongoing rights issue | 1 | Cision News | ||
| 12.02. | The observation status for Qlife Holding AB is updated | 162 | GlobeNewswire | On June 5, 2025, the shares in Qlife Holding AB (the "Company") were given observation status with reference to the Company's decision to enter into a letter of intent for a reverse takeover of Hipro... ► Artikel lesen | |
| 11.02. | Qlife Holding AB Q4 Sales Decline | - | RTTNews | ||
| 11.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October - December 2025 | 140 | GlobeNewswire (Europe) | Positioned for scale in 2026
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - fourth quarter 2025
On 5. October... ► Artikel lesen | |
| 26.01. | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB | 2 | Cision News | ||
| 26.01. | QLife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval | 364 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today announces that the Company has formally submitted its Egoo PHE home-testing system for regulatory approval... ► Artikel lesen | |
| 22.01. | QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7 | 139 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.01. | QLIFE HOLDING AB: Qlife prepares for pharmacy testing in Nordic markets | 1 | Cision News | ||
| 15.01. | QLife Holding AB: Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships | 154 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, together with its partner Hipro Biotechnology Co., Ltd. ("Hipro"), announces a major milestone: the Egoo HbA1c... ► Artikel lesen | |
| 23.12.25 | QLife Holding AB: Qlife provides end-year operational update on key issues | 557 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, provides a year-end operational update on key issues.
Diabetes data
Egoo Health has achieved breakthrough... ► Artikel lesen | |
| 16.12.25 | QLife Holding AB: The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established | 267 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the non-binding Letter of Intent regarding the potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd.... ► Artikel lesen |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 36,550 | -1,19 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers mit einem Kursziel von 52,15 Euro auf "Outperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| FRESENIUS | 43,690 | -1,82 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
16.03.2026 / 17:10... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | -1,38 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 21,600 | +21,76 % | Aktien KW 11 Aktienmärkte hoffen auf TACO-Trade. Je länger der dauert, … News. Porsche. Nordex. 3U Holding. Grenke. Mutares. Gabler. Masterflex. Deutsche Beteiligungs AG. Deutsche Rohstoff. Nordex. Gerresheimer | Aktien: Eine weitere Woche Bomben auf den Iran, keine erkennbaren "Erfolge" - ausser das sinnlos Menschen sterben. Und langsam kommt der amerikanische Angriff bei der Welt an. Steigende Ölpreise an... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,100 | -2,35 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,400 | -0,93 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| OTTOBOCK | 46,420 | -9,78 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97 Euro je Aktie | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Jahresbericht
Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97... ► Artikel lesen | |
| DRAEGERWERK | 85,40 | -2,06 % | Draegerwerk AG & Co. KGaA: Zollentlastung bereits eingepreist, Aufwärtspotenzial wird kleiner, Kursziel erhöht; auf HALTEN gestuft. | Die Zollerlassungen in den USA bieten einen inkrementellen Unterstützungseffekt für die Draegerwerk, jedoch wird der Nutzen voraussichtlich schrittweise erfolgen. Während bestimmte Zölle aufgehoben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 23,440 | -0,59 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28,50 Euro auf "Market-Perform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,210 | -6,36 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| LIFEMD | 3,900 | -4,18 % | LifeMD, Inc. - 8-K, Current Report | ||
| UNITEDHEALTH | 240,20 | -0,10 % | UNITEDHEALTH GROUP INC stabil in ruhiger Marktphase | ||
| ECKERT & ZIEGLER | 13,880 | -1,70 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| HEARTFLOW | 26,040 | +0,66 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| CO-DIAGNOSTICS | 2,550 | -3,41 % | Co-Diagnostics expands South Asia distribution territory |
QLIFE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,001 (+0,30 %) liegt der Kurs bei 0,168 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QLIFE HOLDING AB finden Sie auf Wallstreet Online.